Data presented at the 2006 annual meeting of the North American Association for the Study of Obesity (NAASO) demonstrated that the all natural dietary fiber FBCx preferentially binds saturated dietary fat. The double-blind placebo-controlled clinical trial with obese diabetic volunteers concluded that all volunteers in the active group responded to FBCx, but those that had the highest saturated fat-containing diets experienced the largest adjusted weight loss.

Through the use of dietary recall with the volunteers, the researchers were able to correlate adjusted weight loss with the caloric intake and diet composition of the volunteers’ usual diet. Although there was a significant correlation between the total fat content of the diet and the adjusted weight loss, the correlation with saturated fat was three-fold greater.

ArtJen Complexus Holdings Corp. the producer of FBCx, in collaboration with Dr. George Grunberger, founder of the Grunberger Diabetes Institute, Bloomfield Hills, MI, www.gdi-pc.com conducted this three-month weight loss study. ArtJen President, Dr. Catherine Jen said, “We knew that FBCx was very efficient at binding fat but the finding that FBCx actually prefers saturated fat has been a very exciting surprise.”

Obesity has reached epidemic proportions worldwide. Two-thirds of the adult population of the USA is either overweight or obese. An estimated 17% of the children and adolescents of the USA were overweight in 2004, an increase of 55% from the early 1990s. All natural FBCx is proving to be an effective weapon in the war on obesity.

Following years of research two university professors, Drs. Catherine Jen and Joseph Artiss, have developed what has been described as a “powerful weapon in the war on obesity.”

“We are very pleased that the efficacy and safety of FBCx have been recognized by medically supervised weight loss programs.” said Dr. Artiss. He added that, “This most recent finding will lead to a paradigm shift. Red meat really is not the evil that we have been led to believe, as long as you take FBCx with it.”

About ArtJen Complexus Holdings Corp
ArtJen Complexus Holdings Corp. is the sole manufacturer of FBCx tablets, an all natural, soluble, dietary fiber. FBCx has the very unique ability to bind nine times its own weight in dietary fat. Taken as directed, two tablets of FBCx per fat-containing meal are capable of removing about 25-30% of the calories from a typical North American diet. This facilitates a decrease in body weight of about 1-1½ pounds per week.

For additional information, please visit www.fbcx.com or call toll free 1-877-4-ARTJEN.

Related Health News:

1. Coaching Helps Followers of the Mayo Clinic Diet Get Lasting Results LITTLETON, Colo., March 2 /PRNewswire/ — The highly effective Mayo Clinic Diet, published in 2009, produces even better results when dieters add personal or group...
2. Mylan Announces Clarinex Settlement Agreement PITTSBURGH, April 8 /PRNewswire-FirstCall/ — Mylan Inc. (NASDAQ:MYL) today announced the settlement of all patent litigation relating to Desloratadine Tablets, 5 mg, the generic version...
3. Clinical Research Study Looking for People with Post-Traumatic Stress Disorder Researchers are presently enrolling patients with civilian post-traumatic stress disorder (PTSD) for a clinical research study called the COPE study. Individuals who are having symptoms...
4. Cinergy Health Supports National Nutrition Month in an Effort to Reduce Healthcare Costs AVENTURA, Fla., March 2 /PRNewswire/ — Cinergy Health, a nationwide health insurance agency providing guaranteed issue and short term major medical insurance programs, discusses the...
5. BioMarin to Present at Cowen and Company Health Care Conference NOVATO, Calif., March 2 /PRNewswire-FirstCall/ — BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) today announced that Hank Fuchs, M.D., Chief Medical Officer of BioMarin, will present a company...